C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2011
09/20/2011	CA2183542C Methods and compositions for stimulating bone cells
09/20/2011	CA2115828C Calcium receptor active molecules
09/15/2011	WO2011113065A2 Pegylated polyplexes for polynucleotide delivery
09/15/2011	WO2011113019A2 Ctla4 proteins and their uses
09/15/2011	WO2011112999A2 Lipid-peptide-polymer conjugates and nanoparticles thereof
09/15/2011	WO2011112955A1 Bluetongue virus recombinant vaccines and uses thereof
09/15/2011	WO2011112935A2 Antibody fusion proteins with disrupted heparin-binding activity
09/15/2011	WO2011112891A2 Plant defensive peptides
09/15/2011	WO2011112856A2 Novel protein peptide hydrogels
09/15/2011	WO2011112805A2 Compositions and methods for screening for lyme disease
09/15/2011	WO2011112671A2 Conversion of vascular endothelial cells into multipotent stem-like cells
09/15/2011	WO2011112046A2 High molecular weight recombinant silk or silk-like protein, and micro- or nanoscale spider-web fiber or spider-web-like fiber produced using the recombinant silk or silk-like protein
09/15/2011	WO2011111920A1 Composition comprising rice bran protein hydrolysate for use in culturing of microorganisms
09/15/2011	WO2011111829A1 Method for modifying rna binding protein using ppr motif
09/15/2011	WO2011111820A1 Diagnostic marker for lung cancer or cervical cancer
09/15/2011	WO2011111588A1 Method of inducing the differentiation of germline stem cells, method of expanding the cells, and culture media therefor
09/15/2011	WO2011111393A1 Fc binding protein and method for producing same
09/15/2011	WO2011111051A1 Death associated protein 1 variants and use thereof for modulating autophagy
09/15/2011	WO2011111041A1 Organism with altered carotenoid content and method of producing same
09/15/2011	WO2011111020A1 Streptococcus thermophilus bacterium
09/15/2011	WO2011110953A2 Polyepitope constructs and methods for their preparation and use
09/15/2011	WO2011110655A2 Vaccine
09/15/2011	WO2011110636A1 Immunogenic composition
09/15/2011	WO2011110635A1 Immunogenic composition
09/15/2011	WO2011110634A1 Vaccine composition
09/15/2011	WO2011110604A1 Pd-1 antibody
09/15/2011	WO2011110515A1 Immunoglobulin g fc region binding polypeptide
09/15/2011	WO2011110359A1 Stat3 activation inhibitors
09/15/2011	WO2011110049A1 Anti-hiv fusion polypeptide and use thereof
09/15/2011	WO2011080765A3 Recombinant human bivalent diabody against rabies virus and uses thereof
09/15/2011	WO2011061032A3 Cells, nucleic acids, enzymes, and use thereof, and methods for the production of sophorolipids
09/15/2011	WO2011059836A3 T cell receptor-deficient t cell compositions
09/15/2011	WO2011057248A3 Methods of propagating monkey adenoviral vectors
09/15/2011	WO2009053536A8 Splice variants of gdnf and uses thereof
09/15/2011	US20110225682 Polynucleotides encoding caryophyllene synthase and uses thereof
09/15/2011	US20110225681 Modified Bacillus Thuringiensis Cry6 Proteins For Nematode Control
09/15/2011	US20110225678 Rice promoters for regulation of plant expression
09/15/2011	US20110224645 Treating inflammatory conditions
09/15/2011	US20110224415 Human muty
09/15/2011	US20110224410 Buffers for Controlling the pH of Bone Morphogenetic Proteins
09/15/2011	US20110224409 Sialic acid derivatives
09/15/2011	US20110224407 Type I Interferon Antagonists
09/15/2011	US20110224406 Interleukin-9 receptor mutants
09/15/2011	US20110224153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders
09/15/2011	US20110224152 Synthetic arginine substituted peptides and their use
09/15/2011	US20110224143 Nucleobindin i variant protein compositions and methods of use
09/15/2011	US20110224139 Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
09/15/2011	US20110224135 Use of conkunitzin-s1 for the modulation of glucose-induced insulin secretion
09/15/2011	US20110224133 Highly Potent Peptides To Control Cancer And Neurodegenerative Diseases
09/15/2011	US20110224131 Antifungal paints and coatings
09/15/2011	US20110224100 Designed armadillo repeat proteins
09/15/2011	US20110224095 Expression of functional human olfactory cyclic nucleotide gated (CNG) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators
09/15/2011	US20110223636 Fluorescent protein and chromoprotein
09/15/2011	US20110223616 HuR-Associated Biomarkers
09/15/2011	US20110223611 Lenalidomide and thalidomide immunoassays
09/15/2011	US20110223202 Cationic core-shell peptide nonoparticles
09/15/2011	US20110223189 Agent for treating leishmania infections
09/15/2011	US20110223186 Clostridium toxin, and process for the preparation of immunogenic composition
09/15/2011	US20110223174 Nontypeable Haemophilus Influenzae Virulence Factors
09/15/2011	US20110223173 Botulinum Neurotoxin A Receptor and the Use Thereof
09/15/2011	US20110223172 Soluble Forms of Hendra and Nipah Virus F Glycoprotein and Uses Thereof
09/15/2011	US20110223151 Conjugated proteins with prolonged in vivo efficacy
09/15/2011	US20110223142 Methods and compositions for soft tissue repair
09/15/2011	US20110223133 Therapeutic agent for hematopoietic tumors
09/15/2011	US20110223130 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
09/15/2011	US20110223108 Glucagon-like peptide-2 and its therapeutic use
09/15/2011	CA2792727A1 Therapy for influenza like illness
09/15/2011	CA2792691A1 Vaccine
09/15/2011	CA2792689A1 Immunogenic composition
09/15/2011	CA2792687A1 Immunogenic composition
09/15/2011	CA2792683A1 Vaccine composition
09/15/2011	CA2792118A1 Bluetongue virus recombinant vaccines and uses thereof
09/15/2011	CA2791930A1 Pd-1 antibody
09/14/2011	EP2365087A2 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
09/14/2011	EP2365085A1 Growth hormone fusion protein
09/14/2011	EP2365082A1 BVDV virus-like particles
09/14/2011	EP2365081A2 13 Transmembrane protein expressed in prostate cancer
09/14/2011	EP2365077A1 iRNA agents targeting VEGF
09/14/2011	EP2365004A2 Membrane associated tumor endothelium markers
09/14/2011	EP2364995A1 Conjugation product
09/14/2011	EP2364994A1 Purfied primate CTLA-8 antigens and related reagents
09/14/2011	EP2364992A1 A process for the preparation of poly-alfa-glutamic acid and derivatives thereof
09/14/2011	EP2364991A1 A process for the preparation of poly-alfa-glutamic acid and derivatives thereof
09/14/2011	EP2364735A2 Branched PEG conjugates of GLP-1
09/14/2011	EP2364734A1 Multi-component biological transport systems
09/14/2011	EP2364727A2 Molecular antigen array
09/14/2011	EP2364718A1 Enzyme treatment of foodstuffs for celiac sprue
09/14/2011	EP2364716A2 Compositions and methods for the treatment of natural killer cell related diseases
09/14/2011	EP2364325A1 Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation
09/14/2011	EP2364324A1 Use of inhibitors of plac8 activity for the modulation of adipogenesis
09/14/2011	EP2364323A2 Temperature-induced polynucleotides and uses therefor
09/14/2011	EP2364322A1 Sulfonylurea-responsive repressor proteins
09/14/2011	EP2364166A1 Suppression of cancer
09/14/2011	EP2364162A2 Compositions and methods for diagnosing and treating b-cll
09/14/2011	EP2364156A2 Modified protozoan expressing at least two variable surface proteins (vsp), a vaccine comprising it and procedures, uses, and methods thereof
09/14/2011	EP2275441A9 High affinity HIV T cell receptors
09/14/2011	EP2046826B1 Exendin fusion proteins
09/14/2011	EP2021360B1 CYCLODIPEPTIDE SYNTHETASE AND ITS USE FOR SYNTHESIS OF CYCLO(TYR-Xaa) CYCLODIPEPTIDES
09/14/2011	EP1910407B1 Mutated pseudomonas exotoxins with reduced antigenicity
09/14/2011	EP1761635B1 Non-integrative and non-replicative lentivirus, preparation and uses thereof

1 ... 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 ... 2916